WEST CONSHOHOCKEN, PA — The U.S. Food and Drug Administration has listed a patent covering HemiClor, a 12.5-milligram chlorthalidone tablet for treating hypertension, in its Orange Book, extending intellectual property …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.